Overview

Ivermectin in Treatment of COVID-19

Status:
Recruiting

Trial end date:
2020-08-15

Target enrollment:

Participant gender:

Summary

confirmed cases with COVID-19 will receive ivermectin as a therapeutic option as well as standard of care treatment and will be compared to those that will receive only standard of care ttt

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Zagazig University

Treatments:

Ivermectin